Treatment of Early Systemic Sclerosis by Bosentan

Clinical trial NCT00226889 · TERMINATED

Trial details

NCT number: NCT00226889
Sponsor: Rikshospitalet University Hospital
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Systemic Sclerosis (Scleroderma)

Start date: 2005-01-01
Primary completion: 2009-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.